T 0395/18 (Oligosaccharides for preventing allergic reactions in infants) vom 11.09.2020
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2020:T039518.20200911
- Datum der Entscheidung
- 11. September 2020
- Aktenzeichen
- T 0395/18
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 12703533.5
- IPC-Klasse
- A23C 9/20
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- MATERNAL SUPPLEMENT TO ENHANCE IMMUNE SYSTEM OF AN INFANT
- Name des Antragstellers
- N.V. Nutricia
- Name des Einsprechenden
- Société des Produits Nestlé S.A.
- Kammer
- 3.3.09
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 111(1) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention Art 54(5) (2007)European Patent Convention Art 83 (2007)European Patent Convention R 106 (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)Rules of procedure of the Boards of Appeal Art 12(2) (2020)Rules of procedure of the Boards of Appeal Art 13(1) (2020)Rules of procedure of the Boards of Appeal Art 13(2) (2020)Rules of procedure of the Boards of Appeal Art 25(3) (2020)
- Schlagwörter
- Main request: sufficiency of disclosure - (no)
Auxiliary requests 1 to 6: sufficiency of disclosure - (no)
Auxiliary request 7: added matter - (no); sufficiency of disclosure - (yes)
Admissibility of late filed submissions - (yes)
Violation of the right to be heard - (no)
Serious doubts that a therapeutic effect is achieved - (yes)
Oral proceedings by videoconference - Orientierungssatz
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.